Riskpilot← Back to searchSign inGet full accessRace medical AB
ABActiveOrg 5564799095Ekeby Bruk 2 NWholesale of pharmaceutical and medical goods · NACE 4646Est. 19940 employees
Revenue 2024
SEK 592K
+348% vs 2023
EBITDA margin
-15.2%
+19% vs 2023
Equity ratio
6.4%
Financial strength
Net profit 2024
SEK -89K
+20% vs 2023
| Revenue | SEK 592K | +348% |
| EBITDA | SEK -90K | +19% |
| Net profit | SEK -89K | +20% |
| Total assets | SEK 2,9M | +16% |
| Equity | SEK 184K | -33% |
| Employees | 0 | — |
Legal name
Race medical AB
Org number
5564799095
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18 januari 1994
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall äga, förädla och förvalta aktier och andra värdepapper samt därmed förenlig verksamhet. Tredjepartshandel inom och utom Europa med skyddsutrustning och medicinsk utrustning.
Address
Ekeby Bruk 2 N
Email
nils@ekebybruk.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 11 | 659 | 132 | 592 |
| Staff expenses | — | — | −13 | −0 | — |
| EBITDA | −29 | 2 | 3 | −110 | −90 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −29 | 2 | 3 | −110 | −90 |
| Net financials | — | — | −0 | −0 | 1 |
| Profit before tax | −29 | 2 | 3 | −111 | −89 |
| Tax | −0 | −0 | −2 | — | — |
| Net profit | −29 | 2 | 1 | −111 | −89 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 874 | 2 144 | 3 423 | 2 455 | 2 856 |
| Equity | 180 | 182 | 384 | 273 | 184 |
| Long-term debt | 695 | 1 959 | 2 001 | 2 124 | 2 605 |
| Short-term debt | 0 | 3 | 1 039 | 57 | 67 |
| Total debt | 695 | 1 962 | 3 040 | 2 182 | 2 672 |
EBITDA margin
-15.2%
This company
15.8%
Market median
-196% vs market
20202024
Equity ratio
6.4%
This company
38.2%
Market median
-83% vs market
20202024
Return on equity
-48.3%
This company
18.4%
Market median
-362% vs market
20202024
Net profit margin
-15.0%
This company
8.1%
Market median
-285% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
14.52×
This company
0.62×
Market median
-2242% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (3) | ||
| Deputy Board Member | 2020 – 2022 | |
| Chairman | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RACE Sverige AB
Race medical AB Board members of Race medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Helene Brolin | Deputy Board Member | 0 companies |
| Dariusz Boczar | Chairman | 0 companies |
| Marzena Boczar | Deputy Board Member | 0 companies |
| Nils Gustaf Sebastian Anders Brolin | Board of Directors | 0 companies |
| Ulf Ragnar Cervén | Deputy Board Member | 0 companies |